The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

Huddle, Campus Fund, Blume Founders Fund, and angel investors Nitin Sharma and Sameer Brij Verma participated in the funding ...

The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets ...

A Peninsula biotech startup's acquisition of a Chicago health data firm could transform how heart drugs are developed, ...

Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

The round also saw participation from Huddle, Campus Fund, Blume Founders Fund, and angel investors including Nitin Sharma (Nexus Venture Partners) and Sameer Brij Verma (Northpoint Capital).

SCbio, in partnership with The Massachusetts Biotechnology Council, has selected six emerging life sciences companies to ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...